Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Index by author

January 01, 2025; Volume 46,Issue 1

  1. Balu, Niranjan

    1. Neurovascular/Stroke Imaging
      DANTE-CAIPI Accelerated Contrast-Enhanced 3D T1: Deep Learning–Based Image Quality Improvement for Vessel Wall MRI
      Mona Kharaji, Gador Canton, Yin Guo, Mohamad Hosaam Mosi, Zechen Zhou, Niranjan Balu and Mahmud Mossa-Basha
      American Journal of Neuroradiology January 2025, 46 (1) 49-56; DOI: https://doi.org/10.3174/ajnr.A8424

  2. Barakos, Jerome A.

    1. EDITOR'S CHOICENeurodegenerative Disorder Imaging
      Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
      Petrice M. Cogswell, Trevor J. Andrews, Jerome A. Barakos, Frederik Barkhof, Suzie Bash, Marc Daniel Benayoun, Gloria C. Chiang, Ana M. Franceschi, Clifford R. Jack, Jay J. Pillai, Tina Young Poussaint, Cyrus A. Raji, Vijay K. Ramanan, Jody Tanabe, Lawrence Tanenbaum, Christopher T. Whitlow, Fang F. Yu, Greg Zaharchuk, Michael Zeinah and Tammie S. Benzinger for the ASNR Alzheimer, ARIA, and Dementia Study Group
      American Journal of Neuroradiology January 2025, 46 (1) 24-32; DOI: https://doi.org/10.3174/ajnr.A8469

      This review discusses the 3 key MRI sequences for ARIA monitoring and standardized imaging protocols and provides imaging recommendations for 3 key patient scenarios. All patients on anti-amyloid immunotherapy should have T2* gradient-recalled echo (to evaluate for ARIA-H), 2D or 3D T2 FLAIR (to evaluate for ARIA-E), and DWI (to differentiate ARIA-E from acute ischemia). Patient imaging scenarios are 1) baseline dementia diagnosis/treatment enrollment evaluation, 2) asymptomatic ARIA monitoring, and 3) evaluation of the symptomatic patient on anti-amyloid immunotherapy.

  3. Barboriak, Daniel P.

    1. Letter
      Reply:
      Benjamin M. Ellingson, Francesco Sanvito, Whitney B. Pope, Timothy F. Cloughesy, Raymond Y. Huang, Javier E. Villanueva-Meyer, Daniel P. Barboriak, Lalitha K. Shankar, Marion Smits, Timothy J. Kaufmann, Jerrold L. Boxerman, Michael Weller, Evanthia Galanis, John de Groot, Susan M. Chang, Mark R. Gilbert, Andrew B. Lassman, Mark S. Shiroishi, Ali Nabavizadeh, Minesh Mehta, Roger Stupp, Wolfgang Wick, David A. Reardon, Patrick Y. Wen, Michael A. Vogelbaum and Martin van den Bent
      American Journal of Neuroradiology January 2025, 46 (1) 221-222; DOI: https://doi.org/10.3174/ajnr.A8621

  4. Barkhof, Frederik

    1. EDITOR'S CHOICENeurodegenerative Disorder Imaging
      Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
      Petrice M. Cogswell, Trevor J. Andrews, Jerome A. Barakos, Frederik Barkhof, Suzie Bash, Marc Daniel Benayoun, Gloria C. Chiang, Ana M. Franceschi, Clifford R. Jack, Jay J. Pillai, Tina Young Poussaint, Cyrus A. Raji, Vijay K. Ramanan, Jody Tanabe, Lawrence Tanenbaum, Christopher T. Whitlow, Fang F. Yu, Greg Zaharchuk, Michael Zeinah and Tammie S. Benzinger for the ASNR Alzheimer, ARIA, and Dementia Study Group
      American Journal of Neuroradiology January 2025, 46 (1) 24-32; DOI: https://doi.org/10.3174/ajnr.A8469

      This review discusses the 3 key MRI sequences for ARIA monitoring and standardized imaging protocols and provides imaging recommendations for 3 key patient scenarios. All patients on anti-amyloid immunotherapy should have T2* gradient-recalled echo (to evaluate for ARIA-H), 2D or 3D T2 FLAIR (to evaluate for ARIA-E), and DWI (to differentiate ARIA-E from acute ischemia). Patient imaging scenarios are 1) baseline dementia diagnosis/treatment enrollment evaluation, 2) asymptomatic ARIA monitoring, and 3) evaluation of the symptomatic patient on anti-amyloid immunotherapy.

  5. Barranco, F. David

    1. Neurodegenerative Disorder Imaging
      Automated Detection of Normal Pressure Hydrocephalus Using CT Imaging for Calculating the Ventricle-to-Subarachnoid Volume Ratio
      Jacob J. Knittel, Justin L. Hoskin, Dylan J. Hoyt, Jonathan A. Abdo, Emily L. Foldes, Molly M. McElvogue, Clay M. Oliver, Daniel A. Keesler, Terry D. Fife, F. David Barranco, Kris A. Smith, J. Gordon McComb, Matthew T. Borzage and Kevin S. King
      American Journal of Neuroradiology January 2025, 46 (1) 141-146; DOI: https://doi.org/10.3174/ajnr.A8451

  6. Bash, Suzie

    1. EDITOR'S CHOICENeurodegenerative Disorder Imaging
      Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
      Petrice M. Cogswell, Trevor J. Andrews, Jerome A. Barakos, Frederik Barkhof, Suzie Bash, Marc Daniel Benayoun, Gloria C. Chiang, Ana M. Franceschi, Clifford R. Jack, Jay J. Pillai, Tina Young Poussaint, Cyrus A. Raji, Vijay K. Ramanan, Jody Tanabe, Lawrence Tanenbaum, Christopher T. Whitlow, Fang F. Yu, Greg Zaharchuk, Michael Zeinah and Tammie S. Benzinger for the ASNR Alzheimer, ARIA, and Dementia Study Group
      American Journal of Neuroradiology January 2025, 46 (1) 24-32; DOI: https://doi.org/10.3174/ajnr.A8469

      This review discusses the 3 key MRI sequences for ARIA monitoring and standardized imaging protocols and provides imaging recommendations for 3 key patient scenarios. All patients on anti-amyloid immunotherapy should have T2* gradient-recalled echo (to evaluate for ARIA-H), 2D or 3D T2 FLAIR (to evaluate for ARIA-E), and DWI (to differentiate ARIA-E from acute ischemia). Patient imaging scenarios are 1) baseline dementia diagnosis/treatment enrollment evaluation, 2) asymptomatic ARIA monitoring, and 3) evaluation of the symptomatic patient on anti-amyloid immunotherapy.

  7. Bayraktar, Esref Alperen

    1. Neurointervention
      Triple Aspiration versus Conventional Aspiration Techniques: A Randomized In Vitro Evaluation
      Cem Bilgin, Jiahui Li, Esref Alperen Bayraktar, Ryan M. Naylor, Alexander A. Oliver, Yasuhito Ueki, Jonathan R. Cortese, Lorenzo Rinaldo, Ramanathan Kadirvel, Waleed Brinjikji, Harry J. Cloft and David F. Kallmes
      American Journal of Neuroradiology January 2025, 46 (1) 90-95; DOI: https://doi.org/10.3174/ajnr.A8409

  8. Belsan, Tomáš

    1. Brain Tumor Imaging
      Open Access
      IDH Status in Brain Gliomas Can Be Predicted by the Spherical Mean MRI Technique
      Vojtěch Sedlák, Milan Němý, Martin Májovský, Adéla Bubeníková, Love Engstrom Nordin, Tomáš Moravec, Jana Engelová, Dalibor Sila, Dora Konečná, Tomáš Belšan, Eric Westman and David Netuka
      American Journal of Neuroradiology January 2025, 46 (1) 121-128; DOI: https://doi.org/10.3174/ajnr.A8432

  9. Benayoun, Marc Daniel

    1. EDITOR'S CHOICENeurodegenerative Disorder Imaging
      Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
      Petrice M. Cogswell, Trevor J. Andrews, Jerome A. Barakos, Frederik Barkhof, Suzie Bash, Marc Daniel Benayoun, Gloria C. Chiang, Ana M. Franceschi, Clifford R. Jack, Jay J. Pillai, Tina Young Poussaint, Cyrus A. Raji, Vijay K. Ramanan, Jody Tanabe, Lawrence Tanenbaum, Christopher T. Whitlow, Fang F. Yu, Greg Zaharchuk, Michael Zeinah and Tammie S. Benzinger for the ASNR Alzheimer, ARIA, and Dementia Study Group
      American Journal of Neuroradiology January 2025, 46 (1) 24-32; DOI: https://doi.org/10.3174/ajnr.A8469

      This review discusses the 3 key MRI sequences for ARIA monitoring and standardized imaging protocols and provides imaging recommendations for 3 key patient scenarios. All patients on anti-amyloid immunotherapy should have T2* gradient-recalled echo (to evaluate for ARIA-H), 2D or 3D T2 FLAIR (to evaluate for ARIA-E), and DWI (to differentiate ARIA-E from acute ischemia). Patient imaging scenarios are 1) baseline dementia diagnosis/treatment enrollment evaluation, 2) asymptomatic ARIA monitoring, and 3) evaluation of the symptomatic patient on anti-amyloid immunotherapy.

  10. Benson, John

    1. Spine Imaging and Spine Image-Guided Interventions
      Open Access
      Introduction to Digital Subtraction Myelography for CSF-Venous Fistula Detection
      Ian T. Mark, Ajay A. Madhavan, John Benson, Jared Verdoorn and Waleed Brinjikji
      American Journal of Neuroradiology January 2025, 46 (1) 219; DOI: https://doi.org/10.3174/ajnr.A8587
    2. Spine Imaging and Spine Image-Guided Interventions
      Open Access
      CT-Guided Epidural Contrast Injection for the Identification of Dural Defects
      Ian T. Mark, Michael Oien, John Benson, Jared Verdoorn, Ben Johnson-Tesch, D.K. Kim, Jeremy Cutsforth-Gregory and Ajay A. Madhavan
      American Journal of Neuroradiology January 2025, 46 (1) 207-210; DOI: https://doi.org/10.3174/ajnr.A8437
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue

Advertisement
Advertisement